StockData
GT Biopharma, Inc. logo

GT Biopharma, Inc. (GTBP) stock

GTBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 5/30
$3.18−0.35 (-10.04%)

Close on Nov 17, 2026Market cap $143.45MP/E –Yield –

GT Biopharma profit margin

Profit margin (net margin) is net income as a percentage of revenue.

For fiscal 2015 it was -79485.2%, against -38506.6% the year before. The highest annual figure on record is -136.1% in fiscal 2013.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2015Dec 31, 2015-79485.2%−40978.6
FY2014Dec 31, 2014-38506.6%−38370.4
FY2013Dec 31, 2013-136.1%+1375.8
FY2012Dec 31, 2012-1512.0%+12718.8
FY2011Dec 31, 2011-14230.8%+12996.5
FY2010Dec 31, 2010-27227.3%–

More GT Biopharma figures

See a number that looks wrong?